Quadrant Capital Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$120K Buy
2024
Q4
$115K Hold
2024
Q3
$92.6K Hold
2024
Q2
$54.4K Buy
2024
Q1
$15.9K Sell
2023
Q4
$22.1K Buy
2023
Q3
$358 Buy
2023
Q2
Sell
2023
Q1
$923 Buy
2021
Q4
Sell
2021
Q3
$1K Buy